Efficacy and Safety of Bevacizumab (Avastin®) Combined to Weekly Paclitaxel Followed by Bevacizumab (Avastin®) Alone in Patients With Relapsed Ovarian Sex-cord Stromal Tumours (ALIENOR)

NCT01770301 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Sex-cord Stromal Tumor

Interventions

DRUG: Paclitaxel
DRUG: Bevacizumab

Sponsor

ARCAGY/ GINECO GROUP

Collaborators

[object Object]